Scientific letter
Impact of an endocrine hypertension unit on the diagnosis of primary aldosteronism
Impacto de una consulta de hipertensión endocrina en el diagnóstico del hiperaldosteronismo primario
Jorge Gabriel Ruiz-Sánchez
, Diego Meneses
Corresponding author
Servicio de Endocrinología y Nutrición, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
Read
188
Timeswas read the article
45
Total PDF
143
Total HTML
Share statistics
array:24 [ "pii" => "S2530018023000811" "issn" => "25300180" "doi" => "10.1016/j.endien.2023.05.002" "estado" => "S300" "fechaPublicacion" => "2023-05-01" "aid" => "1397" "copyright" => "SEEN and SED" "copyrightAnyo" => "2023" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Endocrinol Diabetes Nutr. 2023;70:360-2" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S2530016423000484" "issn" => "25300164" "doi" => "10.1016/j.endinu.2023.02.004" "estado" => "S300" "fechaPublicacion" => "2023-05-01" "aid" => "1397" "copyright" => "SEEN y SED" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Endocrinol Diabetes Nutr. 2023;70:360-2" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">CARTA CIENTÍFICA</span>" "titulo" => "Impacto de una consulta de hipertensión endocrina en el diagnóstico del hiperaldosteronismo primario" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "360" "paginaFinal" => "362" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Impact of an endocrine hypertension unit on the diagnosis of primary aldosteronism" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2862 "Ancho" => 1591 "Tamanyo" => 290846 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A) Evolución de los casos atendidos en la consulta según su procedencia desde el servicio de Nefrología (Nefro) y Endocrinología (Endo), y diagnosticados de hiperaldosteronismo primario a lo largo del tiempo. B) Evolución del total de cateterismos venosos suprarrenales (CVS) realizados y de CVS con una adecuada tasa de selectividad bilateral a lo largo del tiempo. C) Diferencia de CVS con adecuada selectividad bilateral en el último mes del 2022, antes y después de una reunión multidisciplinar en la que se autoanalizaron los datos de la consulta.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Jorge Gabriel Ruiz-Sánchez, Diego Meneses" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Jorge Gabriel" "apellidos" => "Ruiz-Sánchez" ] 1 => array:2 [ "nombre" => "Diego" "apellidos" => "Meneses" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2530018023000811" "doi" => "10.1016/j.endien.2023.05.002" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2530018023000811?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2530016423000484?idApp=UINPBA00004N" "url" => "/25300164/0000007000000005/v1_202304241136/S2530016423000484/v1_202304241136/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2530018023000823" "issn" => "25300180" "doi" => "10.1016/j.endien.2023.05.003" "estado" => "S300" "fechaPublicacion" => "2023-05-01" "aid" => "1398" "copyright" => "SEEN and SED" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Endocrinol Diabetes Nutr. 2023;70:362-4" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific letter</span>" "titulo" => "Werner syndrome as a crossroads between lipodystrophy, escleroderma-like changes and torpid ulcers in lower limbs" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "362" "paginaFinal" => "364" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Síndrome de Werner como encrucijada entre lipodistrofia, cambios esclerodérmicos y úlceras tórpidas en miembros inferiores" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Juan de Dios García Díaz, Sandra Coronado Fernández, Sara Jiménez, José Antonio Rubio, Cristina Bohórquez Heras" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Juan de Dios" "apellidos" => "García Díaz" ] 1 => array:2 [ "nombre" => "Sandra" "apellidos" => "Coronado Fernández" ] 2 => array:2 [ "nombre" => "Sara" "apellidos" => "Jiménez" ] 3 => array:2 [ "nombre" => "José Antonio" "apellidos" => "Rubio" ] 4 => array:2 [ "nombre" => "Cristina" "apellidos" => "Bohórquez Heras" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S2530016423000496" "doi" => "10.1016/j.endinu.2023.02.005" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2530016423000496?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2530018023000823?idApp=UINPBA00004N" "url" => "/25300180/0000007000000005/v1_202305311257/S2530018023000823/v1_202305311257/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2530018022001925" "issn" => "25300180" "doi" => "10.1016/j.endien.2021.12.011" "estado" => "S300" "fechaPublicacion" => "2023-05-01" "aid" => "1278" "copyright" => "SEEN and SED" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Endocrinol Diabetes Nutr. 2023;70:352-9" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Sociocultural differences in the development of obesity in adolescents in Murcia" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "352" "paginaFinal" => "359" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Diferencias socioculturales en el desarrollo de la obesidad en adolescentes en Murcia" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1303 "Ancho" => 2917 "Tamanyo" => 203236 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Classification according to the participants' nutritional status by place of origin.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Pedro Juan Carpena Lucas, María Isabel Jiménez Candel, Francisco Sánchez-Cubo, Guillermo Ceballos-Santamaría, Manuel Vargas Vargas, Jośe Mondéjar Jiménez" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Pedro Juan" "apellidos" => "Carpena Lucas" ] 1 => array:2 [ "nombre" => "María Isabel" "apellidos" => "Jiménez Candel" ] 2 => array:2 [ "nombre" => "Francisco" "apellidos" => "Sánchez-Cubo" ] 3 => array:2 [ "nombre" => "Guillermo" "apellidos" => "Ceballos-Santamaría" ] 4 => array:2 [ "nombre" => "Manuel" "apellidos" => "Vargas Vargas" ] 5 => array:2 [ "nombre" => "Jośe" "apellidos" => "Mondéjar Jiménez" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S253001642200060X" "doi" => "10.1016/j.endinu.2021.12.007" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S253001642200060X?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2530018022001925?idApp=UINPBA00004N" "url" => "/25300180/0000007000000005/v1_202305311257/S2530018022001925/v1_202305311257/en/main.assets" ] "en" => array:14 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific letter</span>" "titulo" => "Impact of an endocrine hypertension unit on the diagnosis of primary aldosteronism" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "360" "paginaFinal" => "362" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Jorge Gabriel Ruiz-Sánchez, Diego Meneses" "autores" => array:2 [ 0 => array:4 [ "nombre" => "Jorge Gabriel" "apellidos" => "Ruiz-Sánchez" "email" => array:1 [ 0 => "gajo_saru@hotmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "Diego" "apellidos" => "Meneses" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Servicio de Endocrinología y Nutrición, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Impacto de una consulta de hipertensión endocrina en el diagnóstico del hiperaldosteronismo primario" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2862 "Ancho" => 1591 "Tamanyo" => 276966 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A) Changes in cases seen in the clinic over time according to their origin, referred from the Nephrology (Nephro) or Endocrinology (Endo) departments, and diagnosed with primary aldosteronism. B) Changes over time in the total number of adrenal venous samplings (AVS) performed and in AVS with an adequate bilateral selectivity rate. C) Difference in AVS with adequate bilateral selectivity in the last month of 2022, before and after a multidisciplinary meeting in which the consultation data were self-analysed.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Arterial hypertension (HT) is the main risk factor for cardiovascular disease and it affects ∼50% of the Spanish adult population.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Primary aldosteronism (PA) is a chronic, progressive endocrine disorder that is the main cause of HT; it is found in 10–15% of the hypertensive adult population in general<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> and in 30% in cases of severe and/or resistant HT. PA is a major cardiovascular risk factor.<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3,4</span></a> It increases the risk of death, stroke, coronary heart disease, chronic kidney disease, atrial fibrillation, left ventricular hypertrophy and heart failure more than essential HT and regardless of blood pressure levels. Early detection can therefore save lives and improve the quality of life of those affected.<a class="elsevierStyleCrossRefs" href="#bib0025"><span class="elsevierStyleSup">5,6</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">Considering the public health impact of PA, all clinicians should be familiar with its management. However, the reality is that identifying PA can be complex, which partly explains the high rate of underdiagnosis.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> This seems to be no different among endocrinologists in Spain. Studies from the Spanish PA registry report high rates of hypokalaemia, suggesting that PA is diagnosed in advanced stages, even in very obvious cases.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> A recent Spanish national survey on the treatment of PA by Spanish endocrinologists<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">9</span></a> showed that there is great variability in this area, and that there is a lack of subtyping studies, findings similar to those reported by other authors.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> Additionally, it was reported that only 35% of departments had a specific specialist in PA and that, although 67% had an HT clinic/unit at their hospital, these came under other specialist areas. It is likely that the establishment of specific referral centres/units/clinics in HT with endocrinologists subspecialising in PA would improve the management of this condition.</p><p id="par0015" class="elsevierStylePara elsevierViewall">Our department boasts a specific endocrine hypertension clinic (C-HT-Endo), which has been running since January 2022. We report here how this clinic has affected the diagnosis of PA and we discuss our experiences so far.</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Operational structure of the clinic</span><p id="par0020" class="elsevierStylePara elsevierViewall">Suspected cases of endocrine hypertension, mainly PA, have been channelled to two endocrinologists since July 2021, and the C-HT-Endo has been running as a specific service two days a week since January 2022. In parallel with the creation of the clinic and once it was up and running, informative sessions were held with the hospital's Nephrology, Interventional Radiology, Internal Medicine, Cardiology, Urology and Pathology departments to coordinate diagnostic-therapeutic strategies. The patients are referred from the Nephrology HT clinic or from our own department. The reason for referral is suspected endocrine hypertension, which includes PA, pheochromocytoma/paraganglioma, Cushing's syndrome and acromegaly. In the case of PA, in addition to clinical suspicion, an aldosterone-renin ratio value >20 ng/dl/ng/mL/ with blood aldosterone (Aldo) >8 ng/dl was agreed on (measured with or without drugs that interfere with the renin-angiotensin-aldosterone system). For the diagnosis of PA, apart from clinical exceptions, two of the following functional tests are performed using the published protocol and cut-off points,<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> in accordance with the latest European consensus:<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a> captopril challenge test with captopril 25 mg; oral salt loading test; and intravenous saline loading test. For the study of other causes of endocrine HT, the recommendations of the respective clinical guidelines are followed.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Impact of the C-HT-Endo on the diagnostic approach to PA</span><p id="par0025" class="elsevierStylePara elsevierViewall">From July 2021 to December 2022, 144 patients were seen at the C-HT-Endo, 56 (38.8%) referred from Nephrology and the rest from our department. Of the 144 patients, PA was diagnosed in 46 (31.9%), and no other cause in the rest. With the clinic, compared to previous years, we have seen a markedly progressive increase in the cases investigated and diagnosed with PA, as well as in the number and the diagnostic yield of adrenal venous sampling procedures performed (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>).</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Implications of a C-HT-Endo</span><p id="par0030" class="elsevierStylePara elsevierViewall">First of all, although there are clinical guidelines for the management of HT of endocrine origin, apart from PA, it is still a group of unusual diseases, which are highly heterogeneous from a clinical point of view. The logistical constraints of adapting the approach to the particular situation of each centre and getting a clinic of this type effectively up and running are many. Multidisciplinary coordination with the departments involved is therefore imperative to turn what were initially weaknesses into strengths. Secondly, there is no gold standard for diagnostic or therapeutic action in many of these diseases, especially when "unusual/complicated" cases occur. Moreover, as in the case of PA, the performance of many screening/diagnostic tests can vary depending on pre-analytical factors or cut-off points used, or due to the nature of the disease. In PA, the higher the cut-off point of the aldosterone-renin ratio used for screening, the lower its sensitivity, although the higher its specificity; sitting/standing and some drugs induce different values of aldosterone and renin; and production of aldosterone is not always homogeneous, continuous and completely autonomous. Therefore, doctors who run a C-HT-Endo need to have a thorough knowledge of these situations and be aware that interpreting tests and medical decisions often have to be personalised according to the clinical context. This makes it crucial to have clinical meetings/committees in place for the discussion and study of cases. Lastly, in order to effectively manage endocrine hypertension, it is also necessary to have detailed knowledge of essential hypertension, so training in the field of HT beyond endocrine causes is vitally important.</p><p id="par0035" class="elsevierStylePara elsevierViewall">In conclusion, having a C-HT-Endo has probably led to a more active search for cases of PA by the rest of the physicians, and this would explain the marked increase in the diagnosis of PA in our series. It should also translate into more patients benefiting from better cardiovascular protection after appropriate treatment, which is something we hope to corroborate in the future. We therefore deem the role of an endocrinologist specialising in HT and their participation in HT clinics/units to be vital.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Authors/contributors</span><p id="par0040" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005"><span class="elsevierStyleLabel">1</span><p id="par0045" class="elsevierStylePara elsevierViewall">Conception and design of the manuscript: JGR-S.</p></li><li class="elsevierStyleListItem" id="lsti0010"><span class="elsevierStyleLabel">2</span><p id="par0050" class="elsevierStylePara elsevierViewall">Data collection: JGR-S and DM.</p></li><li class="elsevierStyleListItem" id="lsti0015"><span class="elsevierStyleLabel">3</span><p id="par0055" class="elsevierStylePara elsevierViewall">Data analysis and interpretation: JGR-S.</p></li><li class="elsevierStyleListItem" id="lsti0020"><span class="elsevierStyleLabel">4</span><p id="par0060" class="elsevierStylePara elsevierViewall">Drafting, review and approval of the submitted manuscript: JGR-S and DM.</p></li></ul></p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:5 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Operational structure of the clinic" ] 1 => array:2 [ "identificador" => "sec0010" "titulo" => "Impact of the C-HT-Endo on the diagnostic approach to PA" ] 2 => array:2 [ "identificador" => "sec0015" "titulo" => "Implications of a C-HT-Endo" ] 3 => array:2 [ "identificador" => "sec0020" "titulo" => "Authors/contributors" ] 4 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "multimedia" => array:1 [ 0 => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2862 "Ancho" => 1591 "Tamanyo" => 276966 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A) Changes in cases seen in the clinic over time according to their origin, referred from the Nephrology (Nephro) or Endocrinology (Endo) departments, and diagnosed with primary aldosteronism. B) Changes over time in the total number of adrenal venous samplings (AVS) performed and in AVS with an adequate bilateral selectivity rate. C) Difference in AVS with adequate bilateral selectivity in the last month of 2022, before and after a multidisciplinary meeting in which the consultation data were self-analysed.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:10 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prevalence, Diagnosis, Treatment, and Control of Hypertension in Spain. Results of the Di@bet.es Study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "E. Menéndez" 1 => "E. Delgado" 2 => "F. Fernández-Vega" 3 => "M.A. Prieto" 4 => "E. Bordiú" 5 => "A. Calle" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Rev Española Cardiol (English Ed.)" "fecha" => "2016" "volumen" => "69" "paginaInicial" => "572" "paginaFinal" => "578" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Primary Hyperaldosteronism: When to Suspect It and How to Confirm Its Diagnosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J.G. Ruiz-Sánchez" 1 => "M. Pazos Guerra" 2 => "D. Meneses" 3 => "I. Runkle" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Endocrines" "fecha" => "2022" "volumen" => "3" "paginaInicial" => "29" "paginaFinal" => "42" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Monticone" 1 => "F. D’Ascenzo" 2 => "C. Moretti" 3 => "T.A. Williams" 4 => "F. Veglio" 5 => "F. Gaita" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S2213-8587(17)30319-4" "Revista" => array:6 [ "tituloSerie" => "Lancet Diabetes Endocrinol" "fecha" => "2018" "volumen" => "6" "paginaInicial" => "41" "paginaFinal" => "50" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29129575" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "S. Savard" 1 => "L. Amar" 2 => "P.-F. Plouin" 3 => "O. Steichen" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Hypertens (Dallas, Tex 1979)" "fecha" => "2013" "volumen" => "62" "paginaInicial" => "331" "paginaFinal" => "336" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diagnosis and treatment of primary aldosteronism" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "M. Reincke" 1 => "I. Bancos" 2 => "P. Mulatero" 3 => "U.I. Scholl" 4 => "M. Stowasser" 5 => "T.A. Williams" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S2213-8587(21)00210-2" "Revista" => array:6 [ "tituloSerie" => "Lancet Diabetes Endocrinol" "fecha" => "2021" "volumen" => "9" "paginaInicial" => "876" "paginaFinal" => "892" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34798068" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Primary Aldosteronism: State-of-the-Art Review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "A. Vaidya" 1 => "G.L. Hundemer" 2 => "K. Nanba" 3 => "W.W. Parksook" 4 => "J.M. Brown" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/ajh/hpac079" "Revista" => array:6 [ "tituloSerie" => "Am J Hypertens" "fecha" => "2022" "volumen" => "35" "paginaInicial" => "967" "paginaFinal" => "988" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/35767459" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Keeping primary aldosteronism in mind: Deficiencies in screening at-risk hypertensives" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "B.C. Ruhle" 1 => "M.G. White" 2 => "S. Alsafran" 3 => "E.L. Kaplan" 4 => "P. Angelos" 5 => "R.H. Grogan" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.surg.2018.05.085" "Revista" => array:6 [ "tituloSerie" => "Surgery" "fecha" => "2019" "volumen" => "165" "paginaInicial" => "221" "paginaFinal" => "227" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30415872" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Adrenal venous sampling in primary aldosteronism: Experience of a Spanish multicentric study (Results from the SPAIN-ALDO Register)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Araujo-Castro" 1 => "M. Paja Fano" 2 => "M. González Boillos" 3 => "B. Pla Peris" 4 => "E. Pascual-Corrales" 5 => "A.M. García Cano" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:2 [ "tituloSerie" => "Endocrine" "fecha" => "2022" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "First survey on the diagnosis and treatment of primary aldosteronism by Spanish Endocrinology and Nutrition specialists" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P. Parra Ramírez" 1 => "P. Martín Rojas-Marcos" 2 => "M. Cuesta Hernández" 3 => "J.G. Ruiz-Sánchez" 4 => "C. Lamas Oliveira" 5 => "F.A. Hanzu" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:2 [ "tituloSerie" => "Endocrinol diabetes y Nutr" "fecha" => "2022" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Renal damage in primary aldosteronism" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Monticone" 1 => "E. Sconfienza" 2 => "F. D’Ascenzo" 3 => "F. Buffolo" 4 => "F. Satoh" 5 => "L.A. Sechi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/HJH.0000000000002216" "Revista" => array:6 [ "tituloSerie" => "J Hypertens" "fecha" => "2020" "volumen" => "38" "paginaInicial" => "3" "paginaFinal" => "12" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31385870" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/25300180/0000007000000005/v1_202305311257/S2530018023000811/v1_202305311257/en/main.assets" "Apartado" => array:4 [ "identificador" => "64494" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Scientific letters" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/25300180/0000007000000005/v1_202305311257/S2530018023000811/v1_202305311257/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2530018023000811?idApp=UINPBA00004N" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 3 | 0 | 3 |
| 2024 October | 9 | 1 | 10 |
| 2024 September | 14 | 5 | 19 |
| 2024 August | 15 | 3 | 18 |
| 2024 July | 17 | 3 | 20 |
| 2024 June | 8 | 4 | 12 |
| 2024 May | 8 | 3 | 11 |
| 2024 April | 11 | 13 | 24 |
| 2024 March | 18 | 3 | 21 |
| 2024 February | 11 | 2 | 13 |
| 2024 January | 9 | 0 | 9 |
| 2023 December | 14 | 2 | 16 |
| 2023 November | 6 | 6 | 12 |
Show all
